Inventor · disambiguated record
Catelijne Stortelers
Also filed as: STORTELERS CATELIJNE
22 granted patents·14 pending applications·97 citations·filing 2009–2024
94Inventor score
Top patents by PatentIndex Score
36 records- 0192US10550174B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2017·Granted Feb 4, 2020·6 cites·20 claims
- 0291US9834595B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2015·Granted Dec 5, 2017·6 cites·10 claims
- 0390US9193780B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesHULTBERG ANNA·Filed 2009·Granted Nov 24, 2015·21 cites·19 claims
- 0490US8937164B2Biological materials related to CXCR7DESCAMPS FRANCIS·Filed 2011·Granted Jan 20, 2015·38 cites·14 claims
- 0586US8945567B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsDEPLA ERIK·Filed 2010·Granted Feb 3, 2015·8 cites·8 claims
- 0682US9803001B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsABLYNX NV·Filed 2014·Granted Oct 31, 2017·4 cites·6 claims
- 0778US9644022B2Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infectionsDEPLA ERIK·Filed 2010·Granted May 9, 2017·4 cites·39 claims
- 0876US10273305B2Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activityABLYNX NV·Filed 2016·Granted Apr 30, 2019·2 cites·17 claims
- 0974US11840569B2T cell recruiting polypeptides capable of binding CD123 and TCR alpha/betaABLYNX NV·Filed 2017·Granted Dec 12, 2023·1 cites·16 claims
- 1074US10023633B2Method for generation of immunoglobulin sequencesABLYNX NV·Filed 2016·Granted Jul 17, 2018·1 cites·11 claims
- 1172US9260508B2Method for generation of immunoglobulin sequencesLAEREMANS TOON·Filed 2009·Granted Feb 16, 2016·4 cites·18 claims
- 1271US2024199740A1T cell recruiting polypeptides capable of binding cd123 and tcr alpha/betaABLYNX NV·Filed 2023·Application pending·0 cites
- 1369US10865249B2Antigen-binding polypeptides directed against CD38UNIV MEDICAL CENTER HAMBURG EPPENDORF·Filed 2016·Granted Dec 15, 2020·1 cites·17 claims
- 1469US2024336700A1Antigen-binding polypeptides directed against cd38UNIV MEDICAL CENTER HAMBURG EPPENDORF·Filed 2024·Application pending·0 cites
- 1568US11518799B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2019·Granted Dec 6, 2022·0 cites·10 claims
- 1666US9908935B2P2X7 receptor antagonists and agonistsABLYNX NV·Filed 2013·Granted Mar 6, 2018·1 cites·16 claims
- 1764US11028151B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsABLYNX NV·Filed 2017·Granted Jun 8, 2021·0 cites·11 claims
- 1864US2022242958A1Bispecific nanobodiesABLYNX NV·Filed 2021·Application pending·0 cites
- 1959US12018088B2Antigen-binding polypeptides directed against CD38UNIV MEDICAL CENTER HAMBURG EPPENDORF·Filed 2020·Granted Jun 25, 2024·0 cites·13 claims
- 2058US11046773B2Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activityABLYNX NV·Filed 2019·Granted Jun 29, 2021·0 cites·16 claims
- 2157US9994639B2Biological materials related to CXCR7ABLYNX NV·Filed 2013·Granted Jun 12, 2018·0 cites·8 claims
- 2257US9758584B2Biological materials related to CXCR7ABLYNX NV·Filed 2014·Granted Sep 12, 2017·0 cites·20 claims
- 2357US2025304677A1Blood-Cerebrospinal Fluid Barrier Crossing AntibodiesVIB VZW·Filed 2023·Application pending·0 cites
- 2453US2018355048A1Biological materials related to cxcr7ABLYNX NV·Filed 2018·Application pending·0 cites
- 2553US2024052045A1Murine cross-reactive human ccr8 bindersVIB VZW·Filed 2021·Application pending·0 cites
- 2653US2024052044A1Non-blocking human ccr8 bindersVIB VZW·Filed 2021·Application pending·0 cites
- 2752US2024101647A1Sarbecovirus bindersVIB VZW·Filed 2022·Application pending·0 cites
- 2851US10544216B2P2X7 receptor antagonists and agonistsABLYNX NV·Filed 2018·Granted Jan 28, 2020·0 cites·16 claims
- 2951US2024076391A1Human ccr8 bindersONCURIOUS NV·Filed 2021·Application pending·0 cites
- 3051US2016251440A1Bispecific nanobodiesABLYNX NV·Filed 2014·Application pending·0 cites
- 3149US2023227537A1Corona virus bindersVIB VZW·Filed 2021·Application pending·0 cites
- 3247US2015158948A9Bispecific anti-cxcr7 immunoglobulin single variable domainsDESCAMPS FRANCIS·Filed 2012·Application pending·0 cites
- 3343US10875918B2P2X7 receptor binders and polypeptides comprising the sameABLYNX NV·Filed 2016·Granted Dec 29, 2020·0 cites·8 claims
- 3442US9512236B2Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disordersABLYNX NV·Filed 2012·Granted Dec 6, 2016·0 cites·4 claims
- 3541US2022220197A1Cancer Treatment by Targeting Plexins in the Immune CompartmentVIB VZW·Filed 2020·Application pending·0 cites
- 3630US2011117113A1Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate themBESTE GERALD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Catelijne Stortelers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →